French Innovative Leukemia Organisation

This phase 2 trial tests a new drug called glofitamab combined with standard chemotherapy for people with untreated Richter syndrome, an aggressive lymphoma that can develop in patients with chronic lymphocytic leukemia. The study aims to see if this combination leads to more com…

This study looks back at the medical records of 250 adults with a specific genetic subtype of acute myeloid leukemia (AML) who received the drug Ivosidenib through a special access program in France. The goal is to see how well the drug works and how safe it is in everyday medica…

This study looks at how well current risk scores predict survival and disease progression in people with Waldenstrom's macroglobulinemia, a rare blood cancer. Researchers will follow 500 patients (some with symptoms, some without) to validate and improve these scores. The goal is…

This study is gathering information from 50 people with a rare and aggressive blood cancer called T-cell prolymphocytic leukemia (T-PLL). Researchers will look at medical records, lab results, and genetic data to better understand the disease and how patients respond to current t…